Drug Profile
DK 35C
Latest Information Update: 24 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antibacterials; Carbapenems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 09 Aug 1999 New profile
- 09 Aug 1999 Preclinical development for Bacterial infections in South Korea (Unknown route)